| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| ARGENX | 2 | 10 | +1,39 % | ||
| AB INBEV | 1 | 30 | -0,65 % | ||
| SYENSQO | 1 | 1 | -2,16 % | ||
| MELEXIS | - | 4 | +1,96 % | ||
| ELIA GROUP | - | 4 | +0,63 % | ||
| UMICORE | - | 2 | 0,00 % | ||
| AGEAS | - | 1 | +1,02 % | ||
| KBC GROEP NV | - | 1 | +0,15 % | ||
| GBL | - | 1 | -0,41 % | ||
| MONTEA | - | 1 | -1,94 % |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 11:22 | Berenberg stuft argenx nach starker Rally ab | 5 | Investing.com Deutsch | ||
| 09:42 | DEUTSCHE BANK RESEARCH stuft Argenx auf 'Hold' | 492 | dpa-AFX-Analyser | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat das Kursziel für Argenx von 900 auf 925 Euro angehoben, die auf Rekordniveau befindlichen Aktien aber von "Buy" auf "Hold" abgestuft. Es sei... ► Artikel lesen | |
| 08:58 | Syensqo SA: Participation notification by The Capital Group Companies, Inc. | 214 | GlobeNewswire (Europe) | Press releaseCommuniqué de presse
Participation notification by The Capital Group Companies, Inc.
Brussels, Belgium - August 25, 2026 - 8:45 CEST
According to Belgian transparency legislation... ► Artikel lesen | |
| 07:47 | ANHEUSER-BUSCH INBEV SA/NV - AB InBev reports on the progress of its share buy-back program announced on 30 October 2025 | 4 | SENS | ||
| Mo | Melexis N.V.: Melexis: update on the share buy-back program | 2 | GlobeNewswire (USA) | ||
| Mo | Deutsche Bank downgrades argenx stock to Hold on valuation | 10 | Investing.com | ||
| Mo | Argenx cut to hold at Deutsche Bank following share price run | 10 | Seeking Alpha | ||
| Mo | AB InBev invests in New York Cutwater production | 3 | Just Drinks | ||
| Mo | Elia completes Belgium energy island foundations | 2 | reNews | ||
| Mo | Biotech Stocks At 52-Week Highs - Eloxx Pharmaceuticals, Prelude Therapeutics, argenX, Boundless Bio, Corcept Therapeutics | 373 | AFX News | WASHINGTON (dpa-AFX) - The following biotech stocks reached a 52-week high on August 21, 2026, as new trials continued enrolment and companies released positive clinical research data.Eloxx... ► Artikel lesen | |
| Mo | ANHEUSER-BUSCH INBEV SA/NV - Disclosure Made According to the Requirements of the Law of 2 May 2007 | 6 | SENS | ||
| Sa | argenx SE (ARGX) Won Its Phase 3 Myositis Trial. How Much Does the Subgroup Miss Matter? | 14 | Insider Monkey | ||
| Fr | Europas Biotech-Star: Nicht Moderna: Diese Biotech-Aktie hat nach 11.000-%-Rallye noch Potenzial! | 2.492 | wallstreetONLINE | © Foto: Andrew Brookes - Westend61Seit dem IPO im Jahr 2014 ist die Argenx-Aktie um mehr als 11.150 Prozent gestiegen. Ein Studienerfolg entfacht bei Argenx neue Fantasie. Die Hintergründe Enthaltene... ► Artikel lesen | |
| Fr | Umicore - Transparency notification by BNP Paribas Asset Management Holding and BNP Paribas Cardif | 7 | GlobeNewswire (USA) | ||
| Fr | Montea H1 2026 slides: 95% of growth plan secured, EPS up 5% | 1 | Investing.com | ||
| Fr | Montea Aktie legt nach Hochstufung durch Degroof Petercam zu | 1 | Investing.com Deutsch | ||
| Fr | Anheuser-Busch Invests $13 Mln In Baldwinsville Brewery | 405 | AFX News | WASHINGTON (dpa-AFX) - Anheuser-Busch InBev SA/NV (BUD), a brewer and manufacturer, on Thursday announced a $13 million investment in its Baldwinsville, New York brewery.The investment will... ► Artikel lesen | |
| Do | Anheuser-Busch invests in New York brewery amid strong demand for Michelob Ulta, Cutwater products | 6 | Seeking Alpha | ||
| Do | Azelis: Transparency notifications from UBS Group AG | 427 | Business Wire | REGULATED INFORMATION
In accordance with Article 14 of the Belgian Transparency law of 2 May 2007, Azelis Group NV (Brussels:AZE) announces that on 17 August 2026 and 20 August 2026, it has received... ► Artikel lesen | |
| Do | Lebensmittelsektor meldet sich zurück: Nestlé, Heineken, Anheuser-Busch InBev & Co. jetzt wieder im Fokus für Anleger? | Société Générale |